These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 1360230

  • 21. Proto-oncogene amplification and human breast tumor phenotype.
    Adnane J, Gaudray P, Simon MP, Simony-Lafontaine J, Jeanteur P, Theillet C.
    Oncogene; 1989 Nov; 4(11):1389-95. PubMed ID: 2554239
    [Abstract] [Full Text] [Related]

  • 22. Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas.
    Park JB, Rhim JS, Park SC, Kimm SW, Kraus MH.
    Cancer Res; 1989 Dec 01; 49(23):6605-9. PubMed ID: 2573419
    [Abstract] [Full Text] [Related]

  • 23. Estradiol activation of human colon carcinoma-derived Caco-2 cell growth.
    Di Domenico M, Castoria G, Bilancio A, Migliaccio A, Auricchio F.
    Cancer Res; 1996 Oct 01; 56(19):4516-21. PubMed ID: 8813150
    [Abstract] [Full Text] [Related]

  • 24. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
    Guérin M, Barrois M, Terrier MJ, Spielmann M, Riou G.
    Oncogene Res; 1988 Oct 01; 3(1):21-31. PubMed ID: 2905033
    [Abstract] [Full Text] [Related]

  • 25. Clinical significance of erbB2 protein overexpression.
    Paik S, Burkhard E, Lippman ME.
    Cancer Treat Res; 1992 Oct 01; 61():181-91. PubMed ID: 1360231
    [No Abstract] [Full Text] [Related]

  • 26. Gene expression profiling detects gene amplification and differentiates tumor types in breast cancer.
    Dressman MA, Baras A, Malinowski R, Alvis LB, Kwon I, Walz TM, Polymeropoulos MH.
    Cancer Res; 2003 May 01; 63(9):2194-9. PubMed ID: 12727839
    [Abstract] [Full Text] [Related]

  • 27. Deregulation and overexpression of c-fos proto-oncogene in rat renal cell-lines and primary tumors induced by dimethylnitrosamine.
    Shore SK, Hard GC, Magee PN.
    Oncogene; 1988 Nov 01; 3(5):567-70. PubMed ID: 3152601
    [Abstract] [Full Text] [Related]

  • 28. The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand.
    Lonardo F, Di Marco E, King CR, Pierce JH, Segatto O, Aaronson SA, Di Fiore PP.
    New Biol; 1990 Nov 01; 2(11):992-1003. PubMed ID: 1983208
    [Abstract] [Full Text] [Related]

  • 29. Quantitative detection of amplification of proto-oncogenes in breast cancer.
    Chen Y, Dong J, Lu Y, McGee JO.
    Chin Med J (Engl); 1995 Nov 01; 108(11):849-54. PubMed ID: 8585979
    [Abstract] [Full Text] [Related]

  • 30. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.
    Yu D, Wolf JK, Scanlon M, Price JE, Hung MC.
    Cancer Res; 1993 Feb 15; 53(4):891-8. PubMed ID: 8094034
    [Abstract] [Full Text] [Related]

  • 31. Topoisomerase II alpha co-amplification with erbB2 in human primary breast cancer and breast cancer cell lines: relationship to m-AMSA and mitoxantrone sensitivity.
    Smith K, Houlbrook S, Greenall M, Carmichael J, Harris AL.
    Oncogene; 1993 Apr 15; 8(4):933-8. PubMed ID: 8096076
    [Abstract] [Full Text] [Related]

  • 32. Molecular correlates of cytogenetic abnormalities in human cancer cells: implications for oncogene activation.
    Brodeur GM.
    Prog Hematol; 1986 Apr 15; 14():229-56. PubMed ID: 3003796
    [No Abstract] [Full Text] [Related]

  • 33. Expression of the c-erbB2 gene in the BT474 human mammary tumor cell line: measurement of c-erbB2 mRNA half-life.
    Pasleau F, Grooteclaes M, Gol-Winkler R.
    Oncogene; 1993 Apr 15; 8(4):849-54. PubMed ID: 8096075
    [Abstract] [Full Text] [Related]

  • 34. Oncogenic potential of erbB-2 in human mammary epithelial cells.
    Pierce JH, Arnstein P, DiMarco E, Artrip J, Kraus MH, Lonardo F, Di Fiore PP, Aaronson SA.
    Oncogene; 1991 Jul 15; 6(7):1189-94. PubMed ID: 1713661
    [Abstract] [Full Text] [Related]

  • 35. Expression of c-erbB-2 in human esophageal carcinoma cells: overexpression correlated with gene amplification or with GATA-3 transcription factor expression.
    Shiga K, Shiga C, Sasano H, Miyazaki S, Yamamoto T, Yamamoto M, Hayashi N, Nishihira T, Mori S.
    Anticancer Res; 1993 Jul 15; 13(5A):1293-301. PubMed ID: 7902061
    [Abstract] [Full Text] [Related]

  • 36. Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue.
    Yokota J, Yamamoto T, Miyajima N, Toyoshima K, Nomura N, Sakamoto H, Yoshida T, Terada M, Sugimura T.
    Oncogene; 1988 Mar 15; 2(3):283-7. PubMed ID: 3281095
    [Abstract] [Full Text] [Related]

  • 37. Overexpression of the c-erbB-2 oncogene in sarcomas and small round-cell tumors of childhood. An immunohistochemical investigation.
    George E, Niehans GA, Swanson PE, Strickler JG, Singleton TP.
    Arch Pathol Lab Med; 1992 Oct 15; 116(10):1033-5. PubMed ID: 1358045
    [Abstract] [Full Text] [Related]

  • 38. Expression screening of 17q12-21 amplicon reveals GRB7 as an ERBB2-dependent oncogene.
    Saito M, Kato Y, Ito E, Fujimoto J, Ishikawa K, Doi A, Kumazawa K, Matsui A, Takebe S, Ishida T, Azuma S, Mochizuki H, Kawamura Y, Yanagisawa Y, Honma R, Imai J, Ohbayashi H, Goshima N, Semba K, Watanabe S.
    FEBS Lett; 2012 Jun 12; 586(12):1708-14. PubMed ID: 22584052
    [Abstract] [Full Text] [Related]

  • 39. Allotment of protein-tyrosine kinases belonging to the src-family.
    Toyoshima K, Yamanashi Y, Inoue K, Katagiri T, Sukegawa J, Semba K, Yamamoto T.
    Adv Second Messenger Phosphoprotein Res; 1990 Jun 12; 24():284-9. PubMed ID: 1698408
    [No Abstract] [Full Text] [Related]

  • 40. [Function of oncogenes in neuroepithelial tumors].
    Diedrich U.
    Fortschr Neurol Psychiatr; 1992 Apr 12; 60(4):146-53. PubMed ID: 1601384
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.